Association of Cytokines With the Development of Complications in Burn and Toxic Epidermal Necrolysis (TENS) Patients
1 other identifier
observational
65
1 country
1
Brief Summary
This study will involve blood draws to test for specific cytokines. The study goal is to gain a better understanding of the role of inflammatory response in the development of specific complications in burn and TENS patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Oct 2019
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 2, 2019
CompletedFirst Submitted
Initial submission to the registry
January 28, 2020
CompletedFirst Posted
Study publicly available on registry
February 5, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2022
CompletedAugust 25, 2021
August 1, 2021
3 years
January 28, 2020
August 24, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Cytokine Response that develops into complications
The number of burn and TENS patients that develop subsequent medical complications
up to one year
Study Arms (1)
Blood Draw
This study will involve blood draws to test for specific cytokines
Interventions
Eligibility Criteria
Samples size will be patients from the burn ICU.
You may qualify if:
- is ≥18 years of age
- has been admitted to the Joseph M. Still Burn Center at Doctors Hospital Augusta with a burn diagnosis, or TENS OR SJS diagnosis (confirmed or non-confirmed), with an expected length of stay to be at least 7 days
- the subject or their legally authorized representative is able to provide informed consent
- has a negative urine or serum pregnancy test at screening (if female and has potential for pregnancy)
You may not qualify if:
- is moribund, or in the opinion of the investigator is not expected to survive
- has sustained an electrical burn
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Joseph M. Still Burn Center at Doctors Hospital
Augusta, Georgia, 30909, United States
Biospecimen
Plasma
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michael Quinn, MD
Joseph M. Still Research Foundation, Inc.
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 28, 2020
First Posted
February 5, 2020
Study Start
October 2, 2019
Primary Completion
October 1, 2022
Study Completion
December 1, 2022
Last Updated
August 25, 2021
Record last verified: 2021-08
Data Sharing
- IPD Sharing
- Will share
Study results will be analyzed, and study data presented at an appropriate related Congress meeting. Journal publication in a related peer-reviewed journal would be expected after presentation.